T1	Observation 25 28	BMI
E1	Observation:T1 Name:T88
T2	Eq-Comparison 29 40	>= 25 kg/m2
E2	Eq-Comparison:T2 Operator:T89 Value:T90 Unit:T91 Unit:T92
T3	Age 53 57	aged
E3	Age:T3
T4	Eq-Comparison 58 71	50 - 80 years
E4	Eq-Comparison:T4 Value:T94 Operator:T95 Value:T96 Temporal-Unit:T97
T5	Eq-Comparison 81 91	Successful
E5	Eq-Comparison:T5 Temporal-Recency:T98
T6	Modifier 92 103	biochemical
E6	Modifier:T6
T7	Modifier 105 119	haematological
E7	Modifier:T7
T8	Or 121 124	and
E8	Or:T8
T9	Modifier 125 135	urinalysis
E9	Modifier:T9
T10	Procedure 136 146	assessment
E10	Procedure:T10
T11	Temporal-Connection 147 149	at
E11	Temporal-Connection:T11
A1	Temporal-Connection-Type-Value E11 during
T12	Study 150 159	screening
E12	Study:T12
T13	Eq-Comparison 185 192	Current
E13	Eq-Comparison:T13 Temporal-Period:T101
T14	Condition 193 200	smokers
E14	Condition:T14 Name:T102
T15	Or 202 204	or
E15	Or:T15
T16	Condition 205 215	ex-smokers
E16	Condition:T16 Name:T103
T17	Negation 216 223	ceasing
E17	Negation:T17
T18	Eq-Comparison 224 238	< 6 months ago
E18	Eq-Comparison:T18 Operator:T104 Value:T105 Temporal-Unit:T106
T19	Eq-Comparison 244 252	existing
E19	Eq-Comparison:T19 Temporal-Period:T107
T20	Or 253 255	or
E20	Or:T20
T21	Eq-Comparison 268 272	past
E21	Eq-Comparison:T21 Temporal-Period:T109
T22	Eq-Comparison 281 288	history
E22	Eq-Comparison:T22 Temporal-Period:T110
T23	Condition 292 308	vascular disease
E23	Condition:T23 Name:T111
T24	Or 309 311	or
E24	Or:T24
T25	Modifier 312 319	medical
E25	Modifier:T25
T26	Condition 320 330	conditions
E26	Condition:T26
T27	Assertion 331 340	likely to
E27	Assertion:T27
A2	Assertion-Type-Value E27 hypothetical
T28	Study 352 357	study
E28	Study:T28
T29	Modifier 372 380	Fructose
E29	Modifier:T29
T30	Or 381 383	or
E30	Or:T30
T31	Modifier 384 402	lactose intolerant
E31	Modifier:T31
T32	Or 412 414	or
E32	Or:T32
T33	Allergy 421 430	allergies
E33	Allergy:T33
T34	Procedure 434 446	intervention
E34	Procedure:T34
T35	Procedure 447 457	treatments
E35	Procedure:T35
T36	Procedure 493 513	dietary instructions
E36	Procedure:T36
T37	Other 545 552	another
E37	Other:T37
T38	Study 553 561	research
E38	Study:T38
T39	Procedure 580 600	dietary intervention
E39	Procedure:T39 Name:T114
T40	Or 601 607	and/or
E40	Or:T40
T41	Procedure 620 637	biological fluids
E41	Procedure:T41
T42	Or 637 638	/
E42	Or:T42
T43	Procedure 661 678	therapeutic diets
E43	Procedure:T43
T44	Or 679 681	or
E44	Or:T44
T45	Condition 713 724	weight loss
E45	Condition:T45
T46	Eq-Comparison 725 740	within 2 months
E46	Eq-Comparison:T46 Operator:T118 Value:T119 Temporal-Unit:T120
T47	Temporal-Connection 741 743	of
E47	Temporal-Connection:T47
A3	Temporal-Connection-Type-Value E47 before
T48	Study 744 753	screening
E48	Study:T48
T49	Eq-Comparison 766 772	taking
E49	Eq-Comparison:T49 Temporal-Period:T121
T50	Drug 773 782	flavonoid
E50	Drug:T50 Name:T122
T51	Drug 784 791	nitrate
E51	Drug:T51 Name:T123
T52	Or 792 793	/
E52	Or:T52
T53	Drug 794 812	nitrite containing
E53	Drug:T53 Name:T124
T54	Or 813 815	or
E54	Or:T54
T55	Modifier 816 835	fish oil containing
E55	Modifier:T55
T56	Drug 836 847	supplements
E56	Drug:T56
T57	And 849 852	and
E57	And:T57
T58	Assertion 853 865	unwilling to
E58	Assertion:T58
A4	Assertion-Type-Value E58 hypothetical
T59	Temporal-Connection 879 885	during
E59	Temporal-Connection:T59
A5	Temporal-Connection-Type-Value E59 during
T60	And 887 890	and
E60	And:T60
T61	Eq-Comparison 891 898	1 month
E61	Eq-Comparison:T61 Value:T126 Temporal-Unit:T127
T62	Temporal-Connection 899 908	preceding
E62	Temporal-Connection:T62
A6	Temporal-Connection-Type-Value E62 before
T63	Study 913 918	trial
E63	Study:T63
T64	Or 920 922	or
E64	Or:T64
T65	Assertion 923 935	unwilling to
E65	Assertion:T65
A7	Assertion-Type-Value E65 hypothetical
T66	Other 964 969	other
E66	Other:T66
T67	Drug 970 981	supplements
E67	Drug:T67 Name:T128
T68	Drug 999 1012	hypoglycaemic
E68	Drug:T68 Name:T129
T69	Drug 1014 1031	anti-hypertensive
E69	Drug:T69 Name:T130
T70	Modifier 1033 1044	vasodilator
E70	Modifier:T70
T71	Or 1045 1047	or
E71	Or:T71
T72	Procedure 1048 1075	hormone replacement therapy
E72	Procedure:T72 Name:T132
T73	Drug 1077 1080	HRT
E73	Drug:T73 Name:T133
T74	Drug 1082 1092	medication
E74	Drug:T74
T75	Modifier 1114 1125	biochemical
E75	Modifier:T75
T76	Modifier 1127 1141	haematological
E76	Modifier:T76
T77	Or 1142 1144	or
E77	Or:T77
T78	Modifier 1145 1160	urinary results
E78	Modifier:T78
T79	Or 1161 1163	or
E79	Or:T79
T80	Study 1221 1226	study
E80	Study:T80
T81	Condition 1244 1256	hypertension
E81	Condition:T81
T82	Temporal-Connection 1267 1269	at
E82	Temporal-Connection:T82
A8	Temporal-Connection-Type-Value E82 during
T83	Study 1270 1279	screening
E83	Study:T83
T84	Eq-Comparison 1286 1301	≥ 180 / 110mmHg
E84	Eq-Comparison:T84 Operator:T135 Value:T136 Unit:T137
T85	Assertion 1314 1323	requiring
E85	Assertion:T85
A9	Assertion-Type-Value E85 hypothetical
T86	Procedure 1351 1371	general practitioner
E86	Procedure:T86
T87	Encounter 1376 1385	follow-up
E87	Encounter:T87
T88	Observation-Name 25 28	BMI
A10	Observation-Type-Value T88 vital
T89	Eq-Operator 29 31	>=
A11	Eq-Operator-Value T89 GTEQ
T90	Eq-Value 32 34	25
T91	Eq-Unit 35 37	kg
T92	Eq-Unit 38 40	m2
T93	Life-Stage-And-Gender 46 52	Adults
A12	Life-Stage-And-Gender-Type T93 adult
T94	Eq-Value 58 60	50
T95	Eq-Operator 61 62	-
A13	Eq-Operator-Value T95 BETWEEN
T96	Eq-Value 63 65	80
T97	Eq-Temporal-Unit 66 71	years
A14	Eq-Temporal-Unit-Value T97 year
T98	Eq-Temporal-Recency 81 91	Successful
A15	Eq-Temporal-Recency-Value T98 first-time
T99	Condition-Name 105 119	haematological
T100	Procedure-Name 125 146	urinalysis assessment
T101	Eq-Temporal-Period 185 192	Current
A16	Eq-Temporal-Period-Value T101 present
T102	Condition-Name 193 200	smokers
T103	Condition-Name 208 215	smokers
T104	Eq-Operator 224 225	<
A17	Eq-Operator-Value T104 LT
T105	Eq-Value 226 227	6
T106	Eq-Temporal-Unit 228 234	months
A18	Eq-Temporal-Unit-Value T106 month
T107	Eq-Temporal-Period 244 252	existing
A19	Eq-Temporal-Period-Value T107 present
T108	Severity 256 267	significant
A20	Severity-Value T108 severe
T109	Eq-Temporal-Period 268 272	past
A21	Eq-Temporal-Period-Value T109 past
T110	Eq-Temporal-Period 281 288	history
A22	Eq-Temporal-Period-Value T110 past
T111	Condition-Name 292 308	vascular disease
T112	Stability 341 347	affect
A23	Stability-Value T112 change
T113	Condition-Name 384 402	lactose intolerant
T114	Procedure-Name 580 600	dietary intervention
T115	Drug-Name 620 637	biological fluids
T116	Eq-Temporal-Period 658 660	on
A24	Eq-Temporal-Period-Value T116 present
T117	Observation-Name 713 724	weight loss
A25	Observation-Type-Value T117 measurement
T118	Eq-Operator 725 731	within
A26	Eq-Operator-Value T118 LTEQ
T119	Eq-Value 732 733	2
T120	Eq-Temporal-Unit 734 740	months
A27	Eq-Temporal-Unit-Value T120 month
T121	Eq-Temporal-Period 766 772	taking
A28	Eq-Temporal-Period-Value T121 present
T122	Drug-Name 773 782	flavonoid
T123	Drug-Name 784 791	nitrate
T124	Drug-Name 794 812	nitrite containing
T125	Drug-Name 816 847	fish oil containing supplements
T126	Eq-Value 891 892	1
T127	Eq-Temporal-Unit 893 898	month
A29	Eq-Temporal-Unit-Value T127 month
T128	Drug-Name 970 981	supplements
T129	Drug-Name 999 1012	hypoglycaemic
T130	Drug-Name 1014 1031	anti-hypertensive
T131	Drug-Name 1033 1044	vasodilator
T132	Procedure-Name 1048 1075	hormone replacement therapy
T133	Drug-Name 1077 1080	HRT
T134	Condition-Name 1232 1256	Undiagnosed hypertension
T135	Eq-Operator 1286 1287	≥
A30	Eq-Operator-Value T135 GTEQ
T136	Eq-Value 1288 1291	180
T137	Eq-Unit 1294 1301	110mmHg